4.3 Review

Epidemiology of extended-spectrum β-lactamase and metallo-β-lactamase-producing Escherichia coli in South Asia

期刊

FUTURE MICROBIOLOGY
卷 16, 期 7, 页码 521-535

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/fmb-2020-0193

关键词

Escherichia coli; extended-spectrum β -lactamase; meta-analysis; metallo-β -lactamase; prevalence; South Asia

资金

  1. University of Queensland Research Training Ph.D. scholarship
  2. Australian National Health and Medical Research Council [APP1099452, APP1117065]
  3. Griffith University
  4. NHMRC Investigator Grant [APP1197866]

向作者/读者索取更多资源

The study revealed a high prevalence of ESBLs and MBLs among E. coli clinical isolates in South Asia, with bla(CTX-M-15) and bla(NDM-1) being the most prevalent variants. Comprehensive resistance surveillance is needed in South Asia to guide antibiotic prescribing.
Aim: To determine the prevalence of extended-spectrum beta-lactamase (ESBL) and metallo-beta-lactamase (MBL)-producing Escherichia coli in South Asia. Methodology: A systematic review and meta-analysis of data published in PubMed, EMBASE, Web of Science and Scopus. Results: The pooled prevalence of ESBL and MBL-producing E. coli in South Asia were 33% (95% CI: 27-40%) and 17% (95% CI: 12-24%), respectively. The prevalence of bla(CTX-M) type was 58% (95% CI: 49-66%) with bla(CTX-M-15) being the most prevalent (51%, 95% CI: 40-62%) variant. The most prevalent MBL variant was bla(NDM-1) (33%, 95% CI: 20-50%). Conclusion: This study suggests a high prevalence of ESBLs and MBLs among E. coli clinical isolates. Comprehensive resistance surveillance is required to guide clinicians prescribing antibiotics in South Asia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据